Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Femasys (FEMY) Amortization of Deferred Charges (2023 - 2025)

Femasys posted quarterly Amortization of Deferred Charges of $213897.0 for Q4 2025, down 36.66% year-on-year from $337672.0 in Q4 2024, and down 49.85% on a QoQ basis from $426541.0 in Q3 2025.

Femasys (FEMY) has 3 years of Amortization of Deferred Charges data on file, last reported at $213897.0 in Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 36.66% year-over-year to $213897.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 16.31% YoY), and the FY2025 full-year result was $1.4 million, up 16.31% from the prior year.
  • Amortization of Deferred Charges for Q4 2025 stood at $213897.0, down from $426541.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $426541.0 in Q3 2025 and bottomed at $107963.0 in Q4 2023.
  • The 3-year median for Amortization of Deferred Charges is $310540.0 (2024), against an average of $298620.9.
  • The widest annual swing landed in 2024, when Amortization of Deferred Charges surged 212.77%; it then plunged 36.66% in 2025.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $107963.0 in 2023, then soared by 212.77% to $337672.0 in 2024, then slumped by 36.66% to $213897.0 in 2025.
  • The last three Amortization of Deferred Charges figures came in at $213897.0 (Q4 2025), $426541.0 (Q3 2025), and $389913.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Femasys 22.30 Mn 16.91 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 213,897.00
Dec 31, 2025 213,897.00
Sep 30, 2025 426,541.00
Sep 30, 2025 426,541.00
Jun 30, 2025 389,913.00
Jun 30, 2025 389,913.00
Mar 31, 2025 356,699.00
Mar 31, 2025 356,699.00
Dec 31, 2024 337,672.00
Dec 31, 2024 337,672.00
Sep 30, 2024 310,540.00
Sep 30, 2024 310,540.00
Jun 30, 2024 285,561.00
Jun 30, 2024 285,561.00
Mar 31, 2024 258,802.00
Mar 31, 2024 258,802.00
Dec 31, 2023 107,963.00
Dec 31, 2023 107,963.00